Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 2/20 | 0.55 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | NT5E | P21589 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28183362 | 1.00 | CA5A (0.55) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL27899126 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL28060649 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL28268676 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL8061506 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL6231084 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL2345894 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL4455645 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL28273311 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL28104063 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2312 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746906-A1 | IMMUNOGENIC COMPOSITIONS CONTAINING INACTIVATED INFLUENZA A VIRUS AND CPG OLIGONUCLEOTIDE ADJUVANT AND USES THEREOF | Icahn School of Medicine at Mount Sinai (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4743109-A1 | LYME DISEASE VACCINES COMPRISING AN ADJUVANT AND A BORRELIA OUTER SURFACE PROTEIN A ANTIGEN | Dynavax Technologies Corporation (US) | 2026-05-20 | — | — | EP | claimed |
| EP-4743110-A1 | LYME DISEASE VACCINES COMPRISING AN ADJUVANT AND BORRELIA OUTER SURFACE PROTEIN A AND C ANTIGENS | Dynavax Technologies Corporation (US) | 2026-05-20 | — | — | EP | claimed |
| CN-122029130-A | Precipitated aluminium hydroxide spheres and method for producing same | 赢创运营有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12589144-B2 | Combined norovirus and rotavirus vaccine composition and methods of preparation | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2026-03-31 | — | — | US | claimed |
| US-12582711-B2 | RNA-based adjuvant to enhance the immune response to vaccines and therapeutics | ImmuneSure LLC (US) | 2026-03-24 | — | — | US | claimed |
| US-12569553-B2 | Shingles vaccines comprising a TLR9 agonist | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2026-03-10 | — | — | US | claimed |
| EP-4684013-A1 | NON-HUMAN ANIMALS COMPRISING A GENETICALLY MODIFIED ENDOGENOUS IGHA LOCUS AND METHODS OF MAKING THE SAME | Peking University First Hospital (CN) | 2026-01-28 | — | — | EP | claimed |
| US-20250367277-A1 | STREPTOCOCCAL VACCINES AND METHODS FOR USE | GPN Vaccines Ltd (AU) | 2025-12-04 | — | — | US | claimed |
| US-20250360190-A1 | IMMUNOGENICITY OF A CPG-ADJUVANTED RECOMBINANT PLAGUE VACCINE | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2025-11-27 | — | — | US | claimed |
| EP-2621530-A2 | IMPROVED ADJUVANT SYSTEM FOR VACCINE ADMINISTRATION | Vaxform LLC (US) | 2013-08-07 | — | — | EP | claimed |
| EP-2621524-A1 | IMPROVED VACCINE COMPOSITIONS | Eurocine Vaccines AB (SE) | 2013-08-07 | — | — | EP | claimed |
| EP-2129394-B1 | PAPILLOMAVIRUS VACCINE COMPOSITIONS | MERCK SHARP & DOHME (US) | 2012-06-20 | — | — | EP | claimed |
| WO-2012047265-A2 | IMPROVED ADJUVANT SYSTEM FOR VACCINE ADMINISTRATION | VAXFORM LLC (US) | 2012-04-12 | — | — | WO | claimed |
| WO-2012042003-A1 | IMPROVED VACCINE COMPOSITIONS | EUROCINE VACCINES AB (SE) | 2012-04-05 | — | — | WO | claimed |
| US-7763359-B2 | Reacting phosphoric acid, aluminum sulfate, and sodium hydroxide to form a precipitate, drying the precipitate to form amorphous aluminum ortho-phosphate particles having closed voids, and coating the particles with a binder; substitute for titanium dioxide in waterbased paints | BUNGE FERTILIZANTES S.A. (BR) | 2010-07-27 | — | — | US | claimed |
| US-7709010-B2 | Papillomavirus vaccine compositions | MERCK SHARP & DOHME CORP. (US) | 2010-05-04 | — | — | US | claimed |
| EP-2129394-A1 | PAPILLOMAVIRUS VACCINE COMPOSITIONS | Merck & Co., Inc. (US) | 2009-12-09 | — | — | EP | claimed |
| US-20080248062-A1 | Papillomavirus vaccine compositions | MERCK SHARP & DOHME LLC | 2008-10-09 | — | — | US | claimed |
| WO-2008112125-A1 | PAPILLOMAVIRUS VACCINE COMPOSITIONS | MERCK & CO., INC. (US) | 2008-09-18 | — | — | WO | claimed |